RxDoctor Payments Data

Lisa Schocket, MD

Retina Specialist · Baltimore, MDNPI 1225029929

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $6,000 of the $6,582 with a category attached, or 91.2%. AbbVie accounts for 98.3% of it on its own, with 2 other manufacturers making up the rest. Reporting peaked in 2019 at $6,472 and has fallen 98.6% since, to $89 in 2023.

$6,582in general payments, 2019–2025

Across 12 payments — averaging $548.53 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$6K
  • Johnson & Johnson$89
  • Genentech USA, Inc.$21

What the payments were for

  • Consulting fees$6,00091%
  • Travel & lodging$2003%
  • Food & beverage$3826%

General payments by program year

19
22
23

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie10$6,472
Johnson & Johnson1$89
Genentech USA, Inc.1$21

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$6,582 in reported general payments places this provider in the 75th percentile of 47 retina specialist providers in Maryland.

See all retina specialist providers in Maryland

Medicare billing

Part B allowed, 2024
$947,795
Medicare patients
603
Services billed
9,953

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Bromfenac Sodium24$4,750
SimbrinzaBrinzolamide/Brimonidine Tart14$3,770
Prednisolone Acetate58$3,575
Brimonidine Tartrate15$1,943
Dorzolamide-TimololDorzolamide/Timolol/Pf15$1,093
Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat13$481
Latanoprost12$225

Paid to pharmacies, not to this prescriber.

Other retina specialist in Baltimore

See the full list for Maryland

Where these figures come from

Is this you, or does something look wrong? →